catalog number :
MBS8243211
products type :
Assay Kit
products full name :
Alpha-Galactosidase Microplate Assay Kit
products short name :
[Alpha-Galactosidase]
products name syn :
[EC 3.2.1.22; Alpha-galactosidase; Melibiase; GLA; GALA]
other names :
[alpha-galactosidase; alpha-galactosidase]
other gene names :
[SCO0284; SCF85.12]
storage stability :
Shipped and store at 4 degree C for 6 months.
tested application :
Functional Assay
image1 heading :
Typical Testing Data/Standard Curve (for reference only)
products description :
Background/Introduction: Albumin-to-Creatinine Ratio (ACR) is one of the two markers used to determine chronic kidney disease (CKD). ACR is recommended to be measured on regular basis on people living with Type I and Type II diabetes. ACR is defined as the ratio between albumin (reported in mg/dl) and creatinine (reported in g/dl). This ratio estimates the amount of albumin excreted in urine during a 24 hr period. Albuminuria is diagnosed when ACR is greater than 30 mg albumin/g creatinine. ACR Assay Kit provides a simple, sensitive, and highthroughput adaptable assay that detects albumin (detection range: 0.02-2.5 mg/ml), creatinine (detection range: 0.002-0.5 mg/ml) and Albumin-to-creatinine ratio. The ACR ratio is determined in two steps: First, albumin is determined by using a probe (AB580) that specifically recognizes albumin (Ex/Em = 600/630 nm). Second, creatinine is converted to sarcosine via enzymatic reactions. Sarcosine is specifically oxidized generating a product that reacts with a probe producing a chromophore that can be detected at 570 nm.
ncbi acc num :
NP_624613.1
ncbi gb acc num :
NC_003888.3
ncbi pathways :
Galactose Metabolism Pathway (8471); Galactose Metabolism Pathway (292); Glycerolipid Metabolism Pathway (8526); Glycerolipid Metabolism Pathway (361); Sphingolipid Metabolism Pathway (8532); Sphingolipid Metabolism Pathway (369)